IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 155 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $386,000 | +2.4% | 37,355 | 0.0% | 0.04% | -14.0% |
| Q1 2020 | $377,000 | -24.1% | 37,355 | 0.0% | 0.04% | -2.3% |
| Q4 2019 | $497,000 | -67.4% | 37,355 | -78.9% | 0.04% | -71.6% |
| Q3 2019 | $1,523,000 | -21.5% | 177,455 | 0.0% | 0.16% | -22.1% |
| Q2 2019 | $1,941,000 | -19.2% | 177,455 | 0.0% | 0.20% | -25.5% |
| Q1 2019 | $2,401,000 | – | 177,455 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $183,240,000 | 17.56% |
| HealthInvest Partners AB | 1,450,000 | $16,211,000 | 12.91% |
| Healthcare Value Capital, LLC | 200,000 | $2,236,000 | 4.98% |
| BRIDGER MANAGEMENT, LLC | 2,852,414 | $31,890,000 | 2.98% |
| Camber Capital Management LP | 7,500,000 | $83,850,000 | 2.88% |
| 13D Management LLC | 658,017 | $7,357,000 | 2.72% |
| Brown Capital Management | 20,170,126 | $225,502,000 | 1.68% |
| Healthcare Value Capital, LLC | 50,000 | $559,000 | 1.24% |
| Zebra Capital Management LLC | 59,122 | $661,000 | 0.73% |
| PRICE MICHAEL F | 520,000 | $5,814,000 | 0.70% |